JENNIFER ROARK: Open Payments
NPI 1952307670 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$621 in 33 payments from 7 companies in 2025. Trend: 2023 $470 · 2024 $692 · 2025 $621
Food & beverage: $621
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $282 |
| Amgen Inc. | 17 | $174 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $81 |
| Eisai Inc. | 1 | $28 |
| Phathom Pharmaceuticals, Inc. | 2 | $23 |
| PFIZER INC. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: ZEPBOUND, OTEZLA, TRINTELLIX, MOUNJARO, EVENITY, Leqembi, VOQUEZNA, REPATHA.
Industry payments across GA — which companies pay providers there.
